Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07396584 · ClinicalTrials.gov registry record · Phase 1
HMPL-A580 in Participants With Advanced or Metastatic Solid Tumor
A Phase 1 study, sponsored by Hutchmed.
- Recruiting
- Registry status
- Phase 1
- Development phase
- 186
- Enrollment target
NCT07396584 is a Phase 1 study that is actively recruiting participants, run by Hutchmed. The registered enrollment target is 186 participants.
The verdict
NCT07396584, a Phase 1 study, is actively recruiting participants, sponsored by Hutchmed.
- RECRUITING
- Registry status
- Phase 1
- Development phase
- 186 participants
- Enrollment target
Study Summary
This is a first-in-human, multicenter, open-label, phase I/Ⅱa clinical study of HMPL-A580 in participants with unresectable, advanced or metastatic solid tumors.
Interventions
- DRUG HMPL-A580
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 186 participants |
| Start Date | 2026-03-04 |
| Est. Completion | 2029-01-30 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07396584
The ClinicalTrials.gov registry entry for NCT07396584 describes a study currently listed as recruiting, categorized as Phase 1. The registered enrollment target is 186 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Hutchmed, which has 17 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which HMPL-A580 is the first listed.
NCT07396584 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT07396584 about?
NCT07396584 is a clinical study titled "HMPL-A580 in Participants With Advanced or Metastatic Solid Tumor". This is a first-in-human, multicenter, open-label, phase I/Ⅱa clinical study of HMPL-A580 in participants with unresectable, advanced or metastatic solid tumors.
What is the current status of trial NCT07396584?
This trial is currently recruiting. It is a Phase 1 study. The enrollment target is 186 participants. The study started on 2026-03-04. Estimated completion is 2029-01-30.
What interventions are being tested in trial NCT07396584?
The interventions under investigation include: HMPL-A580 (DRUG).
Who is sponsoring clinical trial NCT07396584?
This trial is sponsored by Hutchmed, which has 17 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.